A detailed history of Financial Architects, Inc transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Financial Architects, Inc holds 2,700 shares of EW stock, worth $200,124. This represents 0.04% of its overall portfolio holdings.

Number of Shares
2,700
Previous 2,700 -0.0%
Holding current value
$200,124
Previous $223,000 13.9%
% of portfolio
0.04%
Previous 0.04%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023

SELL
$74.26 - $84.51 $14,332 - $16,310
-193 Reduced 6.67%
2,700 $223,000
Q4 2022

Feb 06, 2023

BUY
$68.3 - $87.44 $9,630 - $12,329
141 Added 5.12%
2,893 $215,000
Q3 2022

Nov 14, 2022

BUY
$82.37 - $107.29 $226,682 - $295,262
2,752 New
2,752 $227,000
Q2 2022

Aug 11, 2022

SELL
$86.5 - $128.27 $233,550 - $346,329
-2,700 Closed
0 $0
Q1 2022

May 05, 2022

SELL
$101.96 - $128.34 $10,196 - $12,834
-100 Reduced 3.57%
2,700 $318,000
Q4 2021

Feb 14, 2022

BUY
$106.37 - $130.68 $10,637 - $13,068
100 Added 3.7%
2,800 $363,000
Q2 2020

Aug 11, 2020

BUY
$57.54 - $76.95 $103,572 - $138,510
1,800 Added 200.0%
2,700 $187,000
Q4 2018

Feb 01, 2019

SELL
$46.41 - $56.94 $4,641 - $5,694
-100 Reduced 10.0%
900 $138,000
Q3 2018

Oct 29, 2018

BUY
$45.7 - $58.03 $4,570 - $5,803
100 Added 11.11%
1,000 $174,000
Q1 2018

Apr 23, 2018

SELL
$37.19 - $47.45 $31,723 - $40,474
-853 Reduced 48.66%
900 $126,000
Q4 2017

Feb 12, 2018

BUY
$33.79 - $39.39 $4,730 - $5,514
140 Added 8.68%
1,753 $198,000
Q3 2017

Nov 01, 2017

BUY
$36.29 - $38.83 $22,245 - $23,802
613 Added 61.3%
1,613 $176,000
Q3 2017

Oct 23, 2017

BUY
$36.29 - $38.83 $36,290 - $38,830
1,000
1,000 $109,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $45.8B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Financial Architects, Inc Portfolio

Follow Financial Architects, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Architects, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Financial Architects, Inc with notifications on news.